Proportion retained in care at 6 months (including pre-ART and ART care)CD4 (cells/μL) median (IQR):Control: 224 (110–387)Intervention: 264 (137–427)One of the outcomes (proportion initiating ART) was not time delineated, the minimum and maximum time of follow-up was 1 and 36 monthsNo outcome verificationAdjustment for confounding and clustering (age, sex, CD4 count, TB, BMI, education, HIV status). The gene discussed is CD4; the disease is tuberculosis.